| DNMT inhibitors |
Status of Clinical trial |
| SGI-110 |
Preclinical evaluation in progress |
| RG108 |
Preclinical evaluation in progress |
| SGI-1027 |
Preclinical evaluation in progress |
| MG98 |
Preclinical evaluation in progress |
| 5-fluoro-2-deoxycytidine |
Phase I |
| 5-Azacytidine (Vidaza) |
Completed; US FDA approved |
| Decitabine (Dacogen) |
Completed; US FDA approved |
